New cancer clinical trial: A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior VEGFR-targeted Therapy

Published on: October 01, 2018 at 09:30PM

• Tweet
• Share
• Share
• Share
• Share